Angelova, V.T.; Pencheva, T.; Vassilev, N.; K-Yovkova, E.; Mihaylova, R.; Petrov, B.; Valcheva, V.
Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives. Antibiotics 2022, 11, 562.
https://doi.org/10.3390/antibiotics11050562
AMA Style
Angelova VT, Pencheva T, Vassilev N, K-Yovkova E, Mihaylova R, Petrov B, Valcheva V.
Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives. Antibiotics. 2022; 11(5):562.
https://doi.org/10.3390/antibiotics11050562
Chicago/Turabian Style
Angelova, Violina T., Tania Pencheva, Nikolay Vassilev, Elena K-Yovkova, Rositsa Mihaylova, Boris Petrov, and Violeta Valcheva.
2022. "Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives" Antibiotics 11, no. 5: 562.
https://doi.org/10.3390/antibiotics11050562
APA Style
Angelova, V. T., Pencheva, T., Vassilev, N., K-Yovkova, E., Mihaylova, R., Petrov, B., & Valcheva, V.
(2022). Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives. Antibiotics, 11(5), 562.
https://doi.org/10.3390/antibiotics11050562